<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE collection SYSTEM "BioC.dtd">
<collection><source>PMC</source><date>20200427</date><key>pmc.key</key><document><id>3914197</id><infon key="license">CC BY</infon><passage><infon key="article-id_doi">10.1155/2012/640365</infon><infon key="article-id_pmc">3914197</infon><infon key="article-id_pmid">24555139</infon><infon key="elocation-id">640365</infon><infon key="license">This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</infon><infon key="name_0">surname:Gambito;given-names:Renela</infon><infon key="name_1">surname:Chan;given-names:Michael</infon><infon key="name_2">surname:Sheta;given-names:Mohamed</infon><infon key="name_3">surname:Ramirez-Arao;given-names:Precious</infon><infon key="name_4">surname:Gurm;given-names:Harmeet</infon><infon key="name_5">surname:Tunkel;given-names:Allan</infon><infon key="name_6">surname:Nivera;given-names:Noel</infon><infon key="section_type">TITLE</infon><infon key="type">front</infon><infon key="volume">2012</infon><infon key="year">2012</infon><offset>0</offset><text>Gestational Diabetes Insipidus Associated with HELLP Syndrome: A Case Report</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>77</offset><text>Gestational diabetes insipidus is a rare, but well recognized, complication of pregnancy. It is related to excess vasopressinase enzyme activity which is metabolized in the liver. A high index of suspicion of gestational diabetes insipidus is required in a correct clinical setting especially in the presence of other risk factors such as preeclampsia, HELLP syndrome, and twin pregnancies. We are presenting a case of gestational diabetes insipidus in a patient with HELLP syndrome. The newborn in this case also had hypernatremia thereby raising possibilities of vasopressinase crossing the placenta.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>680</offset><text>1. Introduction</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>696</offset><text>Gestational diabetes insipidus is a rare complication of pregnancy, and it is related to excess vasopressinase activity. Measurement of the vasopressinase serum concentrations is not available commercially, and the diagnosis is usually established based on the clinical presentation and the appropriate laboratory studies. We are describing a unique case of gestational diabetes insipidus in a patient with HELLP syndrome. Both mother and infant presented with hypernatremia and dehydration.</text></passage><passage><infon key="section_type">CASE</infon><infon key="type">title_1</infon><offset>1188</offset><text>2. Case Report</text></passage><passage><infon key="section_type">CASE</infon><infon key="type">paragraph</infon><offset>1203</offset><text>A previously healthy 47-year-old woman in her 33rd week of twin gestation presented with progressive lethargy, confusion, polydipsia, and polyuria for approximately one month. She was only on prenatal vitamins, and her prenatal follow-up was unremarkable. On admission, her blood pressure was 108/60âmmHg, pulse 95 beats/minute, temperature 97Â°F, respiratory rate of 17 breaths/min, and saturating 98% on ambient air. Her physical examination was significant for confusion, dry oral mucosa, and gravid abdomen. However, there were no petechial lesions, lower limb edema, or focal neurological deficit. Her cardiac and pulmonary examination was also normal.</text></passage><passage><infon key="section_type">CASE</infon><infon key="type">paragraph</infon><offset>1863</offset><text>Laboratory studies revealed a serum sodium of 171âmEq/L, potassium 4.1âmEq/L, chloride 138âmEq/L, bicarbonate 21âmEq/L, glucose 197âmg/dL, BUN 49âmg/dL, creatinine 3.2âmg/dL, calcium 7.8âmEq/L, total protein 5.4âgm/dL, albumin 1.6âgm/dL, alkaline phosphatase 576âunits/L, AST 391âunits/L, and ALT 443âunits/L. The serum osmolality was 356âmOsm/kg; urine sodium 21âmEq/L and urine osmolality was inappropriately low (225âmOsm/kg). Urinalysis was significant for a specific gravity of 1.008, red blood cells 8â10/high-power field, and 30âmg/dL of protein. Complete blood count showed hemoglobin of 13.7âg/dL, hematocrit 42.6%, white blood cell count 15,200/mm3, and platelet count of 76,000/mm3.</text></passage><passage><infon key="section_type">CASE</infon><infon key="type">paragraph</infon><offset>2595</offset><text>The patient underwent an emergent cesarean section, which was complicated by the demise of one of the twin babies. The other newborn was a female with a birthweight of 2180 grams. APGAR scores were 0, 4, and 7 at one, five, and ten minutes, respectively. Laboratory evaluation of the infant showed serum sodium of 177âmEq/L, potassium 4.4âmEq/L, chloride 140âmEq/L, bicarbonate 14âmEq/L, BUN 49âmEq/L, creatinine 3.2âmg/dL, glucose 30âmg/dL, and calcium 8.3âmEq/L.</text></passage><passage><infon key="section_type">CASE</infon><infon key="type">paragraph</infon><offset>3076</offset><text>The infant received 2 boluses of 10% Dextrose for hypoglycemia and was then placed on Dextrose 10% in water at 6âmL/hour with normal saline at 1âmL/hour via umbilical vein. The hypernatremia and the acute kidney injury corrected over a course of several days with continued fluid administration. Her serum antidiuretic hormone level, at the time of birth, was &lt;0.5âpg/mL (Normal 0.0â4.7âpg/mL).</text></passage><passage><infon key="section_type">CASE</infon><infon key="type">paragraph</infon><offset>3481</offset><text>Postoperatively, the mother continued to be hypernatremic despite IV infusion of hypotonic fluids. On the third day postpartum, the diagnosis of gestational diabetes insipidus was suspected and the patient was started on intranasal DDAVP spray 5âmcg twice a day, after an initial dose of 10âmcg. Marked improvement was seen in the patient's hypernatremia, in which her serum sodium concentrations decreased from 158âmEq/L to143âmEq/L within 30 hours from the initial DDAVP dose (Figure 1), and normalization of her serum osmolality (Figure 2). In addition, clinically she became more alert.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>4080</offset><text>3. Discussion</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>4094</offset><text>Gestational diabetes insipidus is a rare complication of pregnancy that occurs in 4 out of 100,000 pregnancies as discussed by Durr. Symptoms usually develop over a few days and include polyuria, polydipsia, fatigue, nausea, weight loss, and decreased skin turgor. Its pathophysiology is thought to result from increased degradation of arginine vasopressin (AVP) by a placental enzyme called vasopressinase.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>4502</offset><text>Vasopressinase is a cysteine aminopeptidase of molecular weight 330âkDa, and is produced by the placental trophoblasts during pregnancy as discussed by Gordge et al.. Serum concentrations can be detected as early as the 7th week of gestation, reaching the maximum around the 40th week, and are usually undetectable around the 6th week postpartum as described by Davison et al.. Being synthesized from the placenta, higher enzyme concentrations were observed in twin and triple pregnancies.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>4994</offset><text>The primary known action of vasopressinase is in vivo as well as in vitro degradation of vasopressin by removing amino acids from the N-terminus. Since the exogenous desmopressin is deaminated at the N-terminus, it can escape the degrading effect of the vasopressinase and is considered the treatment of choice in patients with gestational diabetes insipidus as demonstrated by Schrier. Vasopressinase is metabolized in the liver, which may explain higher concentrations of the enzyme in patients with fatty liver, hepatitis and preeclampsia as discussed by Barbey et al..</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>5567</offset><text>HELLP syndrome is considered a spectrum of preeclampsia. The pathophysiology is not well understood but has been hypothesized to result from excessive stimulation of V1 receptors by vasopressinase-altered AVP leading to platelet aggregation, vasospasm, endothelial constriction, and brain stimulation as discussed by Krege and Katz. On the other hand, liver dysfunction in patients with HELLP syndrome decreases the degradation of the vasopressinase as described by Ellidokuz et al..</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>6051</offset><text>In our case, the infant was hypernatremic with high serum osmolality and a relatively low ADH level (&lt;0.5âpg/mL). Therefore, it is possible that vasopressinase could have crossed the placenta thereby causing infant's hypernatremia and subsequently could have benefited from dDAVP.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>6334</offset><text>In light of the above case, we recommend maintaining a high index of suspicion of gestational diabetes insipidus in patients who present with typical symptoms and signs especially in the presence of other risk factors such as preeclampsia, HELLP syndrome, and twin pregnancies. In addition, treating the infant with DDAVP besides intravenous fluids may also be beneficial. </text></passage><passage><infon key="fpage">276</infon><infon key="issue">4</infon><infon key="lpage">283</infon><infon key="name_0">surname:Durr;given-names:JA</infon><infon key="pub-id_other">2-s2.0-0023248327</infon><infon key="pub-id_pmid">3554998</infon><infon key="section_type">REF</infon><infon key="source">American Journal of Kidney Diseases</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="year">1987</infon><offset>6708</offset><text>Diabetes insipidus in pregnancy</text></passage><passage><infon key="fpage">51</infon><infon key="issue">1</infon><infon key="lpage">58</infon><infon key="name_0">surname:Gordge;given-names:MP</infon><infon key="name_1">surname:Williams;given-names:DJ</infon><infon key="name_2">surname:Huggett;given-names:NJ</infon><infon key="name_3">surname:Payne;given-names:NN</infon><infon key="name_4">surname:Neild;given-names:GH</infon><infon key="pub-id_other">2-s2.0-0028962464</infon><infon key="pub-id_pmid">7889632</infon><infon key="section_type">REF</infon><infon key="source">Clinical Endocrinology</infon><infon key="type">ref</infon><infon key="volume">42</infon><infon key="year">1995</infon><offset>6740</offset><text>Loss of biological activity of arginine vasopressin during its degradation by vasopressinase from pregnancy serum</text></passage><passage><infon key="fpage">1313</infon><infon key="issue">4</infon><infon key="lpage">1318</infon><infon key="name_0">surname:Davison;given-names:JM</infon><infon key="name_1">surname:Sheills;given-names:EA</infon><infon key="name_2">surname:Barron;given-names:WM</infon><infon key="name_3">surname:Robinson;given-names:AG</infon><infon key="name_4">surname:Lindheimer;given-names:MD</infon><infon key="pub-id_other">2-s2.0-0024604106</infon><infon key="pub-id_pmid">2703533</infon><infon key="section_type">REF</infon><infon key="source">Journal of Clinical Investigation</infon><infon key="type">ref</infon><infon key="volume">83</infon><infon key="year">1989</infon><offset>6854</offset><text>Changes in the metabolic clearance of vasopressin and in plasma vasopressinase throughout human pregnancy</text></passage><passage><infon key="fpage">570</infon><infon key="issue">4</infon><infon key="lpage">572</infon><infon key="name_0">surname:Schrier;given-names:RW</infon><infon key="pub-id_other">2-s2.0-77950620036</infon><infon key="pub-id_pmid">19959721</infon><infon key="section_type">REF</infon><infon key="source">Journal of the American Society of Nephrology</infon><infon key="type">ref</infon><infon key="volume">21</infon><infon key="year">2010</infon><offset>6960</offset><text>Systemic arterial vasodilation, vasopressin, and vasopressinase in pregnancy</text></passage><passage><infon key="fpage">2193</infon><infon key="issue">10</infon><infon key="lpage">2196</infon><infon key="name_0">surname:Barbey;given-names:F</infon><infon key="name_1">surname:Bonny;given-names:O</infon><infon key="name_2">surname:Rothuizen;given-names:L</infon><infon key="name_3">surname:Fulgencio;given-names:G</infon><infon key="name_4">surname:Burnier;given-names:M</infon><infon key="pub-id_other">2-s2.0-0141506989</infon><infon key="section_type">REF</infon><infon key="source">Nephrology Dialysis Transplantation</infon><infon key="type">ref</infon><infon key="volume">18</infon><infon key="year">2003</infon><offset>7037</offset><text>A pregnant woman with de novo polyuria-polydipsia and elevated liver enzymes</text></passage><passage><infon key="fpage">283</infon><infon key="issue">4</infon><infon key="lpage">287</infon><infon key="name_0">surname:Krege;given-names:JH</infon><infon key="name_1">surname:Katz;given-names:VL</infon><infon key="pub-id_other">2-s2.0-0025360930</infon><infon key="pub-id_pmid">2192237</infon><infon key="section_type">REF</infon><infon key="source">Medical Hypotheses</infon><infon key="type">ref</infon><infon key="volume">31</infon><infon key="year">1990</infon><offset>7114</offset><text>A proposed relationship between vasopressinase altered vasopressin and preeclampsia</text></passage><passage><infon key="fpage">602</infon><infon key="issue">6</infon><infon key="lpage">604</infon><infon key="name_0">surname:Ellidokuz;given-names:E</infon><infon key="name_1">surname:Uslan;given-names:I</infon><infon key="name_2">surname:Demir;given-names:S</infon><infon key="name_3">surname:Cevrioglu;given-names:S</infon><infon key="name_4">surname:Tufan;given-names:G</infon><infon key="pub-id_other">2-s2.0-33750932556</infon><infon key="pub-id_pmid">17100823</infon><infon key="section_type">REF</infon><infon key="source">Journal of Obstetrics and Gynaecology Research</infon><infon key="type">ref</infon><infon key="volume">32</infon><infon key="year">2006</infon><offset>7198</offset><text>Transient postpartum diabetes insipidus associated with HELLP syndrome</text></passage><passage><infon key="file">CRIM.NEPHROLOGY2012-640365.001.jpg</infon><infon key="id">fig1</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>7269</offset><text>Serum and urine sodium before and after DDAVP administration.</text></passage><passage><infon key="file">CRIM.NEPHROLOGY2012-640365.002.jpg</infon><infon key="id">fig2</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>7331</offset><text>Serum and urine osmolality before and after DDAVP administration.</text></passage></document></collection>
